Anthrax Vaccine: Human Safety Data—25 years of Experience at USAMRIID and the Safety of a Recent Human Dose Reduction Study

Phillip Pittman, M.D., M.P.H.

U.S. Army Medical Research Institute of Infectious Diseases

11:15–11:45 p.m.

IOM study Veterans and Agent Orange, Methodology

Andrew Olshan, Ph.D.

School of Public Health, University of North Carolina at Chapel Hill

11:45–12:15 p.m.

Genetic Susceptibility

James Hanson, M.D.

National Cancer Institute

12:15–12:45 p.m.


12:45–1:15 p.m.

Chemical Interactions: Pyridostigmine Bromide, DEET, and Permethrin

Mohamed Abou-Donia, Ph.D.

Duke University Medical Center

1:15–1:45 p.m.

PB and Growth Hormone

Keith Friend, M.D.

M.D. Anderson Cancer Center

1:45–2:30 p.m.

Biological Effects of Stress

William Malarkey, M.D.

Ohio State University

2:30–3:30 p.m.

Toxicant-Induced Loss of Tolerance

Claudia Miller, M.D., M.S.

University of Texas Health Science Center at San Antonio

3:30–4:00 p.m.

Chemical Interactions

Ernest Hodgson, Ph.D.

North Carolina State University

4:00–5:00 p.m.

Plenary Session

5:00 p.m.


The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement